https://www.avient.com/resource-center?document_type=221&document_subtype=0&industry=0&product_family=0&product_name=0&op=FILTER RESULTS&form_id=resource_filter_form&page=4
Technical Data Sheets
Safety Data Sheets
Safety Data Sheets
https://www.avient.com/resource-center?document_subtype=0&document_type=221&form_id=resource_filter_form&industry=0&op=FILTER RESULTS&product_family=0&product_name=0&page=4
Technical Data Sheets
Safety Data Sheets
Safety Data Sheets
https://www.avient.com/sites/default/files/2023-10/reSound REC Automotive Interior Grades Product Bulletin.pdf
PRODUCT BULLETIN reSound™ REC Recycled Content TPEs Sustainable TPEs for automotive interiors The demands for improved sustainability continue to drive innovation and change across the transportation industry.
Developed in response to the increased need for sustainable material alternatives, reSound™ REC TPEs provide comparable performance to traditional fossil-based grades, and support goals for reduced waste and carbon emissions.
Designed to meet common OEM requirements, these recycled grades offer similar aesthetics to prime TPEs.
https://www.avient.com/resource-center?document_type=221&all=1
Technical Data Sheets
Safety Data Sheets
Safety Data Sheets
https://www.avient.com/sites/default/files/resources/Terms_and_Conditions_of_Sale_for_Finland_%2528English_Language_Version%2529.pdf
SAFETY & HEALTH INDEMNITY Buyer acknowledges that Seller has furnished to Buyer Material Safety Data Sheets as required under applicable laws and regulations, which include warnings together with safety and health information concerning the Product and/or the containers for such Product.
DATA PROTECTION Buyer hereby agrees that any data in relation with the business relationship between Buyer and Seller may be processed by Seller, in compliance with applicable laws and regulations. 15.
https://www.avient.com/sites/default/files/2021-06/avient-ir-presentation-may-2021-w-non-gaap-recs.pdf
Operating Income $3,783 $4,100 2020PF 2021E Adjusted EPS (1) Financial information is pro forma to include a full year of Clariant Masterbatch business acquisition Previous Guidance Current Guidance $3,783 $4,300 2020PF 2021E $308 $360 2020PF 2021E $308 $410 2020PF 2021E $1.93 $2.40 2020PF 2021E $1.93 $2.80 2020PF 2021E (1) (1)(1) (1)(1) (1) (in millions) (in millions) $442 $457 $560 2019PF 2020PF 2021E $1.74 $1.93 $2.80 2019PF 2020PF 2021E FULL YEAR 2019 – 2021 ORGANIC GROWTH (TOTAL COMPANY) 23 Sales Adjusted EBITDA $3,981 $3,783 $4,300 2019PF 2020PF 2021E + 8% Adjusted EPS (1) Financial information is pro forma to include a full year of Clariant Masterbatch business acquisition (1) (1) (in millions) (in millions) (1)(1) + 27% + 61% (1) (1) 24 BALANCE SHEET • Deleveraging to 1.9x net debt to adjusted EBITDA by the end of 2021 • Driven by record adjusted EBITDA performance and strong free cash flow generation from asset light business • Future cash deployment: M&A, opportunistic share repurchases and balance sheet / continued leverage reduction 3.5x 2.7x 1.9x 2019PF 2020PF 2021E Net Debt / Adjusted EBITDA (1) (1) ($ in millions) 2021E Adjusted EBITDA 560$ Free Cash Flow 275$ Total Debt 1,860 Less: Cash (800) Net Debt 1,060$ 2021E Net Debt / Adjusted EBITDA 1.9x (1) Financial information is pro forma to include a full year of Clariant Masterbatch business acquisition PEER COMPARISONS 25 As a specialty formulator, we don’t require significant capital investment, as compared to the base resin raw material suppliers we purchase from.
D is t. ) K W R R P M P P G A V Y F U L G C P IF F H X L F M C F O E H U N E C L K R A E M N A S H C E S C L G R A A LB Median: 5%Median: 3% Source: Peer data per Bloomberg market data as of April 27, 2021 Avient reflects 2021 estimated revenue of $4,300M and excludes one-time synergy capture CAPEX ($20M) Avient Specialty Formulators Other Chemical/Specialty Companies Free Cash Flow Conversion (1) 2021E (%) Being asset light helps us to generate strong free cash flow that is in line with specialty formulators.
Free cash flow conversion calculated as (EBITDA – Capex) / EBITDA Median: 84% Median: 77% HIGH FREE CASH FLOW CONVERSION Avient reflects 2021 estimated EBITDA of $560M and excludes one-time synergy capture CAPEX ($20M) Source: Peer data per Bloomberg market data as of April 27, 2021 87 89 87 86 82 81 76 88 87 84 82 81 78 77 77 77 76 73 70 69 50 19 A vi en t K W R P P G R P M A V Y F U L G C P F M C IF F H X L U N V R E C L A S H C E B N R F O E E M N G R A H U N K R A S C L A L B Source: Peer data per Bloomberg market data as of April 27, 2021 Total Enterprise Value / 2021E EBITDA Our current valuation with updated guidance implies an EBITDA multiple that is below specialty formulator peers and the majority of our chemical peers.
https://www.avient.com/sites/default/files/2023-11/SEM TPE Product Selector Guide _N. America only_2023.pdf
THERMOPLASTIC ELASTOMERS North America Portfolio PRODUCT SELECTION GUIDE GENERAL PROPERTIES REGULATORY OVERMOLDING PROCESS FEATURES Appearance Hardness Specific Gravity Food Contact UL 94 Suitable Substrates Injection Extrusion ASTM (Shore) ASTM (D792) reSound™ REC Recycled Content Series VX2800-9003 C Natural 47A 0.94 - - PP ✔ - 25% post-consumer recycled (PCR) content (PVB from windshields and laminated glass); 1.77 cradle-to-gate product carbon footprint (PCF) VX2800-9004 C Natural 54A 0.95 - - PP ✔ - 25% PCR content (PVB from windshields and laminated glass) VX2800-0001 I Black 65A 0.89 - - PP ✔ - 25% post-industrial recycled (PIR) content VX2800-0001 I Natural 65A 0.89 - - PP ✔ - 25% PIR content VX2800-0001 C Black 65A 0.89 - - PP ✔ - 25% PCR content (ocean plastics) VX2800-0002 I Black 65A 0.88 - - PP ✔ - 40% PIR content VX2800-0003 C Gray 65A 0.88 ✔ - PP ✔ - 25% PCR/PIR content (food packaging) with application specific FDA rating VX0100-0001 AR I Black 79A 1.05 - - PC, ABS, PC/ABS ✔ - 30% PIR content reSound™ BIO Bio-based Series RS7900-0001 30N Natural 31A 1.00 - - PP ✔ - 35% bio-derived content (Gen 1 biomass) RS7900-0001 45N Natural 48A 1.11 - - PP ✔ - 35% bio-derived content (Gen 1 biomass) RS7900-0001 60N Natural 59A 1.11 - - PP ✔ - 35% bio-derived content (Gen 1 biomass) RS7900-0001 70N Natural 69A 1.09 - - PP ✔ - 35% bio-derived content (Gen 1 biomass) RS2800-0001 30N Natural 33A 0.85 - - PP ✔ - 50–60% bio-derived content (Gen 1 biomass) RS2800-0001 45N Natural 49A 0.85 - - PP ✔ - 50–60% bio-derived content (Gen 1 biomass) RS2800-0001 60N Natural 63A 0.87 - - PP ✔ - 50–60% bio-derived content (Gen 1 biomass) RS2800-0001 70N Natural 71A 0.86 - - PP ✔ - 50–60% bio-derived content (Gen 1 biomass) reSound™ Ultra-Low Carbon Footprint Series RS0200-9001 80 Natural 80A 0.87 - - PP, LDPE ✔ - -0.40 cradle-to-gate PCF RS0200-9001 60 Natural 60A 0.86 - - PP, LDPE ✔ - -0.03 cradle-to-gate PCF FEATURED TPES FOR CONSUMER APPLICATIONS CO NSUM ER Avient’s specialty thermoplastic elastomers (TPEs) are formulated to meet countless performance, application and aesthetic demands.
Backed by decades of TPE expertise, our team can help you choose the best polymer for your product or customize a material to meet your specific challenges.
Contact Avient to tap into our expertise and learn more about our specialty TPEs.
https://www.avient.com/sites/default/files/2023-12/Versaflex TPEs for Gasket of Radial Artery Hemostat_Final.pdf
artery tourniquet ARTERY TOURNIQUET MANUFACTURER G A S K E T O F R A D I A L A R T E R Y H E M O S T A T • Super soft feeling • Increased production efficiency by simple injection process • High transparency • Delivered a series of soft-touch TPEs capable of meeting the desired feel • Formulated solutions to comply with FDA regulation for skin contact • Provided easy molding and assembling by onsite technical and customized durometer Customized Versaflex™ TPEs KEY REQUIREMENTS WHY AVIENT?
https://www.avient.com/sites/default/files/2021-06/avient-ir-presentation-june-2021-w-non-gaap-recs_0.pdf
Operating Income $3,783 $4,100 2020PF 2021E Adjusted EPS (1) Financial information is pro forma to include a full year of Clariant Masterbatch business acquisition Previous Guidance Current Guidance $3,783 $4,300 2020PF 2021E $308 $360 2020PF 2021E $308 $410 2020PF 2021E $1.93 $2.40 2020PF 2021E $1.93 $2.80 2020PF 2021E (1) (1)(1) (1)(1) (1) (in millions) (in millions) $442 $457 $560 2019PF 2020PF 2021E $1.74 $1.93 $2.80 2019PF 2020PF 2021E FULL YEAR 2019 – 2021 ORGANIC GROWTH (TOTAL COMPANY) 23 Sales Adjusted EBITDA $3,981 $3,783 $4,300 2019PF 2020PF 2021E + 8% Adjusted EPS (1) Financial information is pro forma to include a full year of Clariant Masterbatch business acquisition (1) (1) (in millions) (in millions) (1)(1) + 27% + 61% (1) (1) 24 BALANCE SHEET • Deleveraging to 1.9x net debt to adjusted EBITDA by the end of 2021 • Driven by record adjusted EBITDA performance and strong free cash flow generation from asset light business • Future cash deployment: M&A, opportunistic share repurchases and balance sheet / continued leverage reduction 3.5x 2.7x 1.9x 2019PF 2020PF 2021E Net Debt / Adjusted EBITDA (1) (1) ($ in millions) 2021E Adjusted EBITDA 560$ Free Cash Flow 275$ Total Debt 1,860 Less: Cash (800) Net Debt 1,060$ 2021E Net Debt / Adjusted EBITDA 1.9x (1) Financial information is pro forma to include a full year of Clariant Masterbatch business acquisition PEER COMPARISONS 25 As a specialty formulator, we don’t require significant capital investment, as compared to the base resin raw material suppliers we purchase from.
D is t. ) K W R R P M P P G A V Y F U L G C P H X L F M C F O E IF F H U N E C L A S H E M N K R A C E S C L G R A A LB Median: 5%Median: 3% Source: Peer data per Bloomberg market data as of June 4, 2021 Avient reflects 2021 estimated revenue of $4,300M and excludes one-time synergy capture CAPEX ($20M) Avient Specialty Formulators Other Chemical/Specialty Companies Free Cash Flow Conversion (1) 2021E (%) Being asset light helps us to generate strong free cash flow that is in line with specialty formulators.
Free cash flow conversion calculated as (EBITDA – Capex) / EBITDA Median: 84% Median: 78% HIGH FREE CASH FLOW CONVERSION Avient reflects 2021 estimated EBITDA of $560M and excludes one-time synergy capture CAPEX ($20M) Source: Peer data per Bloomberg market data as of June 4, 2021 87 89 87 86 83 81 76 88 85 83 82 81 80 78 78 78 76 72 71 69 50 18 A vi en t K W R P P G R P M A V Y F U L G C P F M C H X L U N V R IF F E C L A S H F O E C E E M N B N R H U N G R A K R A S C L A L B Source: Peer data per Bloomberg market data as of June 4, 2021 Total Enterprise Value / 2021E EBITDA Our current valuation with updated guidance implies an EBITDA multiple that is below specialty formulator peers and the majority of our chemical peers.
https://www.avient.com/sites/default/files/2021-09/avnt-seaport-conference-presentation.pdf
Operating Income $3,783 $4,300 2020PF 2021E Adjusted EPS (1) Financial information is pro forma to include a full year of Clariant Masterbatch business acquisition Previous Guidance Current Guidance $3,783 $4,650 2020PF 2021E $308 $410 2020PF 2021E $308 $430 2020PF 2021E $1.93 $2.80 2020PF 2021E $1.93 $3.00 2020PF 2021E (1) (1)(1) (1)(1) (1) (in millions) (in millions) $442 $457 $580 2019PF 2020PF 2021E $1.74 $1.93 $3.00 2019PF 2020PF 2021E FULL YEAR 2019 – 2021 ORGANIC GROWTH (TOTAL COMPANY) 22 Sales Adjusted EBITDA $3,981 $3,783 $4,650 2019PF 2020PF 2021E + 17% Adjusted EPS (1) Financial information is pro forma to include a full year of Clariant Masterbatch business acquisition (1) (1) (in millions) (in millions) (1)(1) + 31% + 72% (1) (1) ($ in millions) 2021E Adjusted EBITDA 580$ Free Cash Flow 280$ Total Debt 1,860 Less: Cash (755) Net Debt 1,105$ 2021E Net Debt / Adjusted EBITDA 1.9x 23 BALANCE SHEET • Acquisition of Magna Colours completed on July 1 – expands sustainable solutions portfolio through water-based inks technology • Deleveraging to 1.9x net debt to adjusted EBITDA by the end of 2021 • Driven by record adjusted EBITDA performance and strong free cash flow generation from asset light business • Future cash deployment: M&A, opportunistic share repurchases and balance sheet / continued leverage reduction 3.5x 2.7x 1.9x 2019PF 2020PF 2021E Net Debt / Adjusted EBITDA (1) (1) (1) Financial information is pro forma to include a full year of Clariant Masterbatch business acquisition SUSTAINABILITY FOR A BETTER TOMORROW 24 • Revenue from sustainable solutions expected to grow 14% in 2021 as our innovation efforts and collaboration with customers continues to accelerate • Investments centered around innovation and global sustainability megatrends o Enabling a circular economy – Technologies that allow for increased use of post-consumer recycled (PCR) material and improve recyclability of plastics o Light-weighting – Composites and CAI applications to reduce weight and material requirements, which minimize energy and carbon emissions o Eco-Conscious – Health and human safety applications as well as Avient’s alternative materials to replace lead, PVC, halogens, BPA and other less eco-friendly options 24 2016 2017 2018 2019 2020PF** Bio-polymers Reduced Energy Use Human Health & Safety Sustainable Infrastructure VOC Reduction Recycle Solutions Eco-Conscious Lightweighting Revenue From Sustainable Solutions* 2016-2020 $405M $455M *Avient Sustainable Solutions definitions aligned with FTC 2012 Guide for the Use of Environmental Marketing Claims (“Green Guides”) **2020 is Pro Forma to include full year of the Clariant Masterbatch business $340M $550M $790M 24 25 Key Updates • Includes Clariant Masterbatch performance • Increases disclosures and ESG data • Provides performance updates on 2030 Sustainability Goals • Commits to operational carbon neutrality in 2050 and 100% renewable energy by 2050 (RE 100) • Announces Avient’s participation in U.N.
D is t. ) K W R P P G A V Y F U L R P M G C P H X L F M C H U N IF F E C L A S H K R A E M N C E S C L A LB Median: 5%Median: 3% Source: Peer data per Bloomberg market data as of July 28, 2021 Avient reflects 2021 estimated revenue of $4,650M and excludes one-time synergy capture CAPEX ($20M) Avient Specialty Formulators Other Chemical/Specialty Companies Free Cash Flow Conversion (1) 2021E (%) Being asset light helps us to generate strong free cash flow that is in line with specialty formulators.
Free cash flow conversion calculated as (EBITDA – Capex) / EBITDA Median: 81% Median: 78% HIGH FREE CASH FLOW CONVERSION Avient reflects 2021 estimated EBITDA of $580M and excludes one-time synergy capture CAPEX ($20M) Source: Peer data per Bloomberg market data as of July 28, 2021 87 90 86 82 80 78 73 87 82 82 79 79 78 78 77 76 71 67 46 A vi en t K W R P P G A V Y F U L R P M G C P F M C U N V R C E IF F A S H E C L B N R E M N H X L H U N K R A S C L A L B (6) Source: Peer data per Bloomberg market data as of July 28, 2021 Total Enterprise Value / 2021E EBITDA Our current valuation with updated guidance implies an EBITDA multiple that is below specialty formulator peers and the median of other selected chemical / specialty companies.